New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
09:16 EDTC, HLIT, KOG, WLL, ACM, URS, EXEL, PGNX, ABBV, SHPG, ABT, MYL, RVBD, EBAY, AAPL, KNDIOn The Fly: Pre-market Movers
HIGHER: Citigroup (C), up 3.6% after reporting better than expected Q2 results, announcing $7B settlement with DOJ and FDIC... Apple (AAPL), up 0.7% after Barclays upgrades stock to Overweight, Morgan Stanley raises Apple estimates above consensus... Shire (SHPG), up 1.6% after receiving revised proposal from AbbVie (ABBV) of GPB 53.20 per share, which it says it would be willing to recommend to Shire shareholders. AbbVie is down 2.8% after the news... Mylan (MYL), up 4% after acquiring Abbott's (ABT) non-U.S. developed markets specialty and branded generics business in all-stock transaction valued at about $5.3B. Abbott up 1.6% after the news... Progenics (PGNX), up 13% after FDA says RELISTOR can be approved on data submitted in sNDA... Exelixis (EXEL), up 13% after announcing coBRIM Phase 3 trial met primary endpoint... URS (URS) up 8% after acquired by AECOM Technology (ACM) for $56.31 per share. AECOM shares alos up 2% after deal announcement... Whiting Petroleum (WLL), up 4.5% after agreeing to acquire Kodiak Oil & Gas (KOG) in a $6B transaction. Kodiak Oil & Gas up 3%... Kandi Technologies (KNDI), up 11% after announcing JV's sale of 4,114 EVs in Q2. LOWER: Riverbed (RVBD), down 4.5% after saying it sees its Q2 adjusted EPS at low end of 26c-28c range... Harmonic (HLIT), down 13% after reporting preliminary Q2 earnings results.. EBay (EBAY), down 0.5% after downgraded at Pacific Crest, confirming partnership plans with Sotheby's (BID).
News For C;AAPL;EBAY;RVBD;MYL;ABT;SHPG;ABBV;PGNX;EXEL;URS;ACM;WLL;KOG;HLIT;KNDI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>
October 16, 2014
10:01 EDTCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:46 EDTAAPLApple October weekly volatility elevated into iPad event and Q4
Subscribe for More Information
09:39 EDTC, AAPLActive equity options trading on open
Subscribe for More Information
09:23 EDTEBAYOn The Fly: Pre-market Movers
Subscribe for More Information
08:58 EDTABBVAllergan was pressured by AbbVie news, says BMO Capital
Subscribe for More Information
08:52 EDTABBV, SHPGAbbVie price target lowered to $59 from $71 at BMO Capital
Subscribe for More Information
08:42 EDTCUBS, DOJ in talks for forex rigging settlement, FT reports
Subscribe for More Information
08:41 EDTEBAY, EBAYeBay downgraded to Underperform from Buy at CLSA
CLSA downgraded eBay to Underperform to reflect ongoing issues with Marketplaces, execution risks post split, diminishing PayPal competitive advantages, and potential M& barriers. Price target lowered to $52 from $66.
08:07 EDTACM, URSAECOM, URS announce preliminary merger consideration
Subscribe for More Information
08:06 EDTAAPLAlmunia says political pressure around Google case 'unprecented,' WSJ reports
Subscribe for More Information
07:50 EDTEBAYeBay shares approaching compelling levels, says Stifel
Subscribe for More Information
07:48 EDTAAPLSony must decide quickly what to do with smartphone strategy, Nikkei says
Sony's (SNE) "One Sony" strategy is built around providing contents to consumers and smartphones are one of three pillars it sees for growth, but the strategy is "on the brink of collapse" as the company falls behind Apple (AAPL) and Chinese rivals, according to the Nikkei Asian Review. Sony officials are debating whether smartphone operations in Asia should be downsized and whether cutting 1,000 jobs, or 15% of its mobile communications workforce, would be warranted, according to the report. Reference Link
07:29 EDTCCitigroup upgraded to Hold from Sell at Argus
Argus upgraded Citigroup to Hold based on valuation and management's progress in improving the loan portfolio and reducing expenses.
07:21 EDTCCFA Institute to hold a conference
Subscribe for More Information
07:06 EDTEBAYeBay downgraded to Sector Perform from Outperform at RBC Capital
Subscribe for More Information
07:01 EDTEBAYeBay price target lowered to $60 from $63 at Cantor
Subscribe for More Information
06:17 EDTABBV, SHPGJefferies says Medtronic 'needs to do' Covidien takeover
Jefferies says it "can't see how Medtronic walks" from the Covidien (COV) takeover given how compelling the merger is. The firm confirmed with Medtronic (MDT) that nothing has changed in the company's commitment to the deal since new financing terms were announced on October 3. In Jefferies view, "Medtronic needs to do this deal." It notes the spread on the acquisition widened significantly on the news that Abbvie (ABBV) is reconsidering its acquisition of Shire (SHPG).
05:50 EDTSHPGStocks with implied volatility movement; SHPG SIRI
Subscribe for More Information
05:37 EDTSHPG, ABBVShire releases statement regarding AbbVie withdrawal of recommendation
Subscribe for More Information
05:21 EDTSHPG, ABBVAbbVie recommends holders vote against Shire transaction
Following Shire's (SHPG) waiver of the three-day notice period, AbbVie (ABBV) announces its board withdraws its recommendation made on July 18 regarding the proposed Shire transaction and recommends that stockholders vote against the transaction. AbbVie and its board made this determination following a detailed consideration of the impact of the U.S. Department of Treasury's unilateral changes to the tax rules, as issued on September 22. The breadth and scope of the changes, including the unexpected nature of the exercise of administrative authority to impact longstanding tax principles, and to target specifically a subset of companies that would be treated differently than either other inverted companies or foreign domiciled entities, introduced an unacceptable level of uncertainty to the transaction. Additionally, the changes eliminated certain of the financial benefits of the transaction, most notably the ability to access current and future global cash flows in a tax efficient manner as originally contemplated in the transaction. This fundamentally changed the implied value of Shire to AbbVie in a significant manner. Under the conditions of AbbVie's offer and the terms of the Co-operation Agreement, the withdrawal of the recommendation alone will not cause a lapse of AbbVie's offer or terminate the Co-operation Agreement between AbbVie and Shire. Unless Shire and the U.K. Takeover Panel agree otherwise, AbbVie must convene an AbbVie stockholder meeting to consider the adoption of the U.S. merger agreement. AbbVie's offer will lapse if the company's stockholders do not adopt the agreement. Assuming Shire provides the requisite cooperation and consents, a pre-effective amendment to the registration statement filed by AbbVie Private Limited in connection with the combination is expected to be filed with the SEC as soon as practicable. Under the terms of the Co-operation Agreement, following the withdrawal of the AbbVie Board of Directors' recommendation, a break fee of approximately $1.64B will be payable to Shire if either: AbbVie stockholders do not approve the adoption of the U.S. merger agreement at an AbbVie stockholder meeting; or such a meeting does not occur by December 14.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use